These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34273950)

  • 21. Establishment of human induced pluripotent stem cell line (SDQLCHi060-A) from a patient with AUTS2 syndrome carrying a heterozygous mutation in AUTS2 gene.
    Gao C; Liu Y; Liu N; Li Z; Yang X; Yang Y; Xi Y; Tian J; Gai Z
    Stem Cell Res; 2023 Dec; 73():103242. PubMed ID: 37948839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
    Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
    Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects.
    Martinez-Delgado B; Lopez-Martin E; Lara-Herguedas J; Monzon S; Cuesta I; Juliá M; Aquino V; Rodriguez-Martin C; Damian A; Gonzalo I; Gomez-Mariano G; Baladron B; Cazorla R; Iglesias G; Roman E; Ros P; Tutor P; Mellor S; Jimenez C; Cabrejas MJ; Gonzalez-Vioque E; Alonso J; Bermejo-Sánchez E; Posada M
    Am J Med Genet A; 2021 Mar; 185(3):877-883. PubMed ID: 33346930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helsmoortel-Van der Aa syndrome in a 13-year-old girl with autistic spectrum disorder, dysmorphism, a right solitary kidney, and polycystic ovaries: a case report.
    Al-Enezi E; Alghamdi M; Al-Enezi K; AlBalwi M; Davies W; Eyaid W
    J Med Case Rep; 2024 Sep; 18(1):422. PubMed ID: 39232847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A ZFHX4 mutation associated with a recognizable neuropsychological and facial phenotype.
    Fontana P; Ginevrino M; Bejo K; Cantalupo G; Ciavarella M; Lombardi C; Maioli M; Scarano F; Costabile C; Novelli A; Lonardo F
    Eur J Med Genet; 2021 Nov; 64(11):104321. PubMed ID: 34461323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TBL1XR1 associated intellectual disability, a new missense variant with dysmorphic features plus autism: Expanding the phenotypic spectrum.
    Arroyo Carrera I; Fernández-Burriel M; Lapunzina P; Tenorio JA; García Navas VD; Márquez Isidro E
    Clin Genet; 2021 Jun; 99(6):812-817. PubMed ID: 33527360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurodevelopmental disorder caused by an inherited novel KMT5B variant: case report.
    Odak L; Vulin K; Meašić AM; Šamadan L; Tripalo Batoš A
    Croat Med J; 2023 Oct; 64(5):334-338. PubMed ID: 37927187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The autism spectrum phenotype in ADNP syndrome.
    Arnett AB; Rhoads CL; Hoekzema K; Turner TN; Gerdts J; Wallace AS; Bedrosian-Sermone S; Eichler EE; Bernier RA
    Autism Res; 2018 Sep; 11(9):1300-1310. PubMed ID: 30107084
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Splice variant in ARX leading to loss of C-terminal region in a boy with intellectual disability and infantile onset developmental and epileptic encephalopathy.
    Shoubridge C; Jackson M; Grinton B; Berkovic SF; Scheffer IE; Huskins S; Thomas A; Ware T
    Am J Med Genet A; 2019 Aug; 179(8):1483-1490. PubMed ID: 31145546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ZNF462 and KLF12 are disrupted by a de novo translocation in a patient with syndromic intellectual disability and autism spectrum disorder.
    Cosemans N; Vandenhove L; Maljaars J; Van Esch H; Devriendt K; Baldwin A; Fryns JP; Noens I; Peeters H
    Eur J Med Genet; 2018 Jul; 61(7):376-383. PubMed ID: 29427787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotypic spectrum associated with PTCHD1 deletions and truncating mutations includes intellectual disability and autism spectrum disorder.
    Chaudhry A; Noor A; Degagne B; Baker K; Bok LA; Brady AF; Chitayat D; Chung BH; Cytrynbaum C; Dyment D; Filges I; Helm B; Hutchison HT; Jeng LJ; Laumonnier F; Marshall CR; Menzel M; Parkash S; Parker MJ; ; Raymond LF; Rideout AL; Roberts W; Rupps R; Schanze I; Schrander-Stumpel CT; Speevak MD; Stavropoulos DJ; Stevens SJ; Thomas ER; Toutain A; Vergano S; Weksberg R; Scherer SW; Vincent JB; Carter MT
    Clin Genet; 2015 Sep; 88(3):224-33. PubMed ID: 25131214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants.
    Kloth K; Lozic B; Tagoe J; Hoffer MJV; Van der Ven A; Thiele H; Altmüller J; Kubisch C; Au PYB; Denecke J; Bijlsma EK; Lessel D
    Neurogenetics; 2021 Oct; 22(4):263-269. PubMed ID: 34218362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Mouse Mutation That Dysregulates Neighboring
    Weisner PA; Chen CY; Sun Y; Yoo J; Kao WC; Zhang H; Baltz ET; Troy JM; Stubbs L
    G3 (Bethesda); 2019 Nov; 9(11):3891-3906. PubMed ID: 31554716
    [No Abstract]   [Full Text] [Related]  

  • 36. Brief Report: SETD2 Mutation in a Child with Autism, Intellectual Disabilities and Epilepsy.
    Lumish HS; Wynn J; Devinsky O; Chung WK
    J Autism Dev Disord; 2015 Nov; 45(11):3764-70. PubMed ID: 26084711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Auts2 regulated autism-like behavior, glucose metabolism and oxidative stress in mice.
    Liu M; Chen Y; Sun M; Du Y; Bai Y; Lei G; Zhang C; Zhang M; Zhang Y; Xi C; Ma Y; Wang G
    Exp Neurol; 2023 Mar; 361():114298. PubMed ID: 36525998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Truncating Variants in NAA15 Are Associated with Variable Levels of Intellectual Disability, Autism Spectrum Disorder, and Congenital Anomalies.
    Cheng H; Dharmadhikari AV; Varland S; Ma N; Domingo D; Kleyner R; Rope AF; Yoon M; Stray-Pedersen A; Posey JE; Crews SR; Eldomery MK; Akdemir ZC; Lewis AM; Sutton VR; Rosenfeld JA; Conboy E; Agre K; Xia F; Walkiewicz M; Longoni M; High FA; van Slegtenhorst MA; Mancini GMS; Finnila CR; van Haeringen A; den Hollander N; Ruivenkamp C; Naidu S; Mahida S; Palmer EE; Murray L; Lim D; Jayakar P; Parker MJ; Giusto S; Stracuzzi E; Romano C; Beighley JS; Bernier RA; Küry S; Nizon M; Corbett MA; Shaw M; Gardner A; Barnett C; Armstrong R; Kassahn KS; Van Dijck A; Vandeweyer G; Kleefstra T; Schieving J; Jongmans MJ; de Vries BBA; Pfundt R; Kerr B; Rojas SK; Boycott KM; Person R; Willaert R; Eichler EE; Kooy RF; Yang Y; Wu JC; Lupski JR; Arnesen T; Cooper GM; Chung WK; Gecz J; Stessman HAF; Meng L; Lyon GJ
    Am J Hum Genet; 2018 May; 102(5):985-994. PubMed ID: 29656860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Intellectual developmental disability overlapping with autism spectrum disorder and attention deficit-hyperactivity disorder].
    Mulas F; Rojas M
    Medicina (B Aires); 2018; 78 Suppl 2():63-68. PubMed ID: 30199368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further evidence of a causal association between AGO1, a critical regulator of microRNA formation, and intellectual disability/autism spectrum disorder.
    Sakaguchi A; Yamashita Y; Ishii T; Uehara T; Kosaki K; Takahashi T; Takenouchi T
    Eur J Med Genet; 2019 Jun; 62(6):103537. PubMed ID: 30213762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.